Dravet syndrome (DS) is one of the most severe genetic epilepsies of childhood. Charlotte
Dravet described severe myoclonic epilepsy in infancy in 1978. Shortly after the initial report …

Richard P. Morse, MD Dravet syndrome is a severe childhood epilepsy characterized by
intractable seizures and neurodevelopmental delay. First described in 1978 by Dravet as …

Stiripentol (marketed by Biocodex as Diacomit®) is an anticonvulsant drug, structurally
unrelated to any other compound, which has recently been approved as adjunctive therapy …

Background Dravet syndrome is a developmental and epileptic encephalopathy that occurs
as a result of SCN1A mutations in more than 80% of affected individuals. The core clinical …

Dravet syndrome is one of the most severe epilepsy syndromes of early childhood, and it
comes with very high morbidity and mortality. The typical presentation is characterized by …

To report the authors' experience with diagnosis and management of Dravet syndrome, or
severe myoclonic epilepsy in infancy, in the era of commercially available genetic testing …

Introduction: Dravet syndrome is an early childhood-onset epilepsy syndrome characterized
by drug-resistant seizures, frequent episodes of status epilepticus, and the development of …

Abstract" Dravet syndrome"(DS) previously named severe myoclonic epilepsy of infancy
(SMEI), or epilepsy with polymorphic seizures, is a rare disorder characterized by an early …

Dravet syndrome is a rare and severe type of epilepsy.“Severe myoclonic epilepsy in
infancy” was first described in 1978 by Charlotte Dravet, who observed common features …

Severe myoclonic epilepsy in infancy (SMEI) is a genetically determined severe epileptic
encephalopathy that was first described by Charlotte Dravet in 19781 and was included in …